(Q79317890)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17075577%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

title

Intrahepatic insulin resistance in a murine model of steatohepatitis: effect of PPARgamma agonist pioglitazone (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17075577%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

1 reference

1 reference

Isabelle A Leclercq

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17075577%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Valérie A Lebrun

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17075577%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Peter Stärkel

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17075577%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Yves J Horsmans

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17075577%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

publication date

30 October 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17075577%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

published in

Laboratory Investigation

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17075577%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

volume

87

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17075577%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17075577%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

page(s)

56-65

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17075577%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/labinvest.3700489

21 December 2019

exact match

0 references

cites work

The mechanisms of action of PPARs

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700489

7 January 2021

https://api.crossref.org/works/10.1038%2FLABINVEST.3700489

1 reference

7 January 2021

Treatment of insulin resistance with peroxisome proliferator-activated receptor gamma agonists

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700489

7 January 2021

PPARs and the complex journey to obesity

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700489

7 January 2021

Adiponectin: a relevant player in PPARgamma-agonist-mediated improvements in hepatic insulin sensitivity?

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700489

7 January 2021

Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700489

7 January 2021

Minireview: lipid metabolism, metabolic diseases, and peroxisome proliferator-activated receptors

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700489

7 January 2021

The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700489

7 January 2021

Liver peroxisome proliferator-activated receptor gamma contributes to hepatic steatosis, triglyceride clearance, and regulation of body fat mass.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700489

7 January 2021

Muscle-specific Pparg deletion causes insulin resistance

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700489

7 January 2021

Muscle-specific PPARgamma-deficient mice develop increased adiposity and insulin resistance but respond to thiazolidinediones

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700489

7 January 2021

Antidiabetic thiazolidinediones inhibit collagen synthesis and hepatic stellate cell activation in vivo and in vitro.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700489

7 January 2021

Expression of peroxisome proliferator-activated receptor γ (PPARγ) in normal human pancreatic islet cells

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700489

7 January 2021

Macrophage differentiation to foam cells

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700489

7 January 2021

Attenuation of colon inflammation through activators of the retinoid X receptor (RXR)/peroxisome proliferator-activated receptor gamma (PPARgamma) heterodimer. A basis for new therapeutic strategies

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700489

7 January 2021

Pathology of nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700489

7 January 2021

Insulin resistance: a metabolic pathway to chronic liver disease

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700489

7 January 2021

Cellular mechanisms of insulin resistance

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700489

7 January 2021

Association of nonalcoholic fatty liver disease with insulin resistance.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700489

7 January 2021

Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700489

7 January 2021

Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700489

7 January 2021

Development of muscle insulin resistance after liver insulin resistance in high-fat-fed rats

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700489

7 January 2021

Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700489

7 January 2021

CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700489

7 January 2021

Curcumin inhibits NF-kappaB activation and reduces the severity of experimental steatohepatitis in mice

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700489

7 January 2021

Central role of PPARalpha-dependent hepatic lipid turnover in dietary steatohepatitis in mice

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700489

7 January 2021

Administration of the potent PPARalpha agonist, Wy-14,643, reverses nutritional fibrosis and steatohepatitis in mice

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700489

7 January 2021

NF-kappaB activation, rather than TNF, mediates hepatic inflammation in a murine dietary model of steatohepatitis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700489

7 January 2021

JNK1 but not JNK2 promotes the development of steatohepatitis in mice

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700489

7 January 2021

The methionine-choline deficient dietary model of steatohepatitis does not exhibit insulin resistance

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700489

7 January 2021

Hepatocyte CYP2E1 overexpression and steatohepatitis lead to impaired hepatic insulin signaling.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700489

7 January 2021

The mechanisms by which both heterozygous peroxisome proliferator-activated receptor gamma (PPARgamma) deficiency and PPARgamma agonist improve insulin resistance

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700489

7 January 2021

Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700489

7 January 2021

Adiponectin and adiponectin receptors

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700489

7 January 2021

Adipocyte-specific gene expression and adipogenic steatosis in the mouse liver due to peroxisome proliferator-activated receptor gamma1 (PPARgamma1) overexpression

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700489

7 January 2021

Calorie restriction, SIRT1 and metabolism: understanding longevity

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700489

7 January 2021

Effects of caloric restriction on insulin pathway gene expression in the skeletal muscle and liver of normal and long-lived GHR-KO mice

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700489

7 January 2021

Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta)

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700489

7 January 2021

Potentiation of insulin signaling in tissues of Zucker obese rats after acute and long-term treatment with PPARgamma agonists

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700489

7 January 2021

Induction of adipocyte complement-related protein of 30 kilodaltons by PPARgamma agonists: a potential mechanism of insulin sensitization

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700489

7 January 2021

Pioglitazone ameliorates insulin resistance and diabetes by both adiponectin-dependent and -independent pathways

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700489

7 January 2021

Peroxisome proliferator-activated receptors in inflammation control

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700489

7 January 2021

The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700489

7 January 2021

Cytokines in alcoholic and nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700489

7 January 2021

Activation of mitogen-activated protein kinases by peroxisome proliferator-activated receptor ligands: an example of nongenomic signaling

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700489

7 January 2021